Guerbet reinforces its expertise with the launch of Contrast&Care®, a contrast media injection management solution for radio...
23 November 2017 - 6:00PM
Contrast&Care® has
just obtained CE mark
Contrast&Care will be presented
at the RSNA
Villepinte (France), November 23, 2017 (8:00 CET) -
Guerbet (FR0000032526 GBT), the global specialist in contrast
products and solutions for medical imaging, today announces the
launch of Contrast&Care®, a new
contrast media injection management solution for radiology
centers.
The launch of the solution is part
of the strategy of Guerbet to develop a portfolio of digital
solutions to optimize the care and management of patients by
healthcare professionals.
Contrast&Care®
is an integrated IT solution that groups together all the
information related to exams requiring the injection of contrast
media (contrast media, injection protocol, patient data, etc.) and
that interfaces with information systems used in radiology such as
the Radiology Information System (RIS) or the Picture Archiving and
Communication System (PACS).
The information generated by
compatible injectors is transmitted automatically to
Contrast&Care® at the end of
each exam. This enables users to view the history of each patient,
the exams with injection that have been performed and the doses of
contrast media administered. Contrast&Care also offers the
option of reviewing protocols, creating protocol libraries, and
viewing statistics and trends relative to injection activity and
the use of contrast media.
"Contrast&Care®was conceived by Guerbet to improve traceability and help
healthcare professionals make decisions on a daily basis. With
these new digital solutions, Contrast&Care® today, and Dose&Care® launched at the beginning of 2017, Guerbet has completed
its integrated offers so radiology centers may make the most of the
technological advances available today.", comments Levi Cheng,
Director of the Imaging Solutions & Services Business Unit.
The commercial launch of
Contrast&Care® will start at
the beginning of 2018.
The Guerbet teams will present
Contrast&Care® at all the
upcoming international radiological congresses where specialists
will perform interactive demonstrations (at the RSNA booth #1341
Hall A, the ECR, etc...).
Contrast&Care®
is a class I /CE medical device designed to be used by
healthcare professionals only. It is a contrast product injection
management solution that enables imaging centers to collect,
archive, examine and share injection data, including data on
contrast products, adverse events, injector activity, information
on estimated glomerular filtration rate (eGFR) and other risk
factors before an exam.
For more information, please refer
to the information leaflet and instructions for use.
Contrast&Care® is
manufactured by Medex, a subsidiary of the Guerbet Group
(Saint-Priest France).
Dose&Care® is a
solution for managing and analyzing the dose of X Rays patients
receive during medical imaging exams. It is intended for use by
medical and diagnostic imaging professionals and by the personnel
in charge of safety and X Ray administration in imaging
centers.
For more information, please refer
to the information leaflet and instructions for use.
Dose&Care® is a
class I /CE medical device manufactured by MPTronic (Paris,
France) and distributed by Guerbet, (Roissy CdG cedex, France).
Guerbet is a pioneer in the
contrast agent field with over 90 years' experience and is one of
the leaders in medical imaging worldwide. The Group offers a full
range of pharmaceutical products, medical devices and services for
X-ray (RX) and Magnetic Resonance Imaging (MRI) scanners and
Interventional Radiology Theranostics (IRT) to improve the
diagnosis and treatment of patients. With 7% of its revenue
dedicated to R&D and more than 200 employees working in three
centers in France and the United States, Guerbet invests heavily in
research and innovation. Guerbet (GBT) is listed on Euronext Paris
(Segment B - Mid Caps) and generated €776 million in revenue in
2016. For more information about Guerbet, visit www.guerbet.com
Guerbet
Global
Alize RP
Caroline Carmagnol et Wendy Rigal
+33 (0)1 44 54 36 66 /
+33 (0)6 48 82 18 94
guerbet@alizerp.com |
|
Press Release
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: GUERBET via Globenewswire
Guerbet (EU:GBT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Guerbet (EU:GBT)
Historical Stock Chart
From Jul 2023 to Jul 2024